CharlesBPorterMDFACC, FAHA, FICOS
Cardiology • Kansas City, KSProfessor, Cardiovascular Disease, University Kansas School of Medicine
Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
University of Kansas Med Center
4000 Cambridge MS 1023
Kansas City, KS 66160Phone+1 913-588-9697Fax+1 913-588-9450- Is this information wrong?
Summary
- I founded the CardioOncology Program at the University of Kansas Medical Center in 2007. My primary commitment is to the KUMC Cardiooncology program’s advancement of patient care, research, education and training. I have continuous experience in heart failure since helping found the first cardiac transplant program in Kansas City Mo in 1985.
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Cardiovascular Disease, 1980 - 1983
University of Kansas School of MedicineResidency, Internal Medicine, 1977 - 1980- University of Kansas School of MedicineClass of 1977
Certifications & Licensure
MO State Medical License 1982 - 2025
KS State Medical License 1978 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Top MD Consumers Checkbook
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Dynamic Thoracic Impedance as a Marker for Heart Failure Decompensation Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 1 citationsA novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.Anup Kasi, Pramod Gaudel, Manidhar Lekkala, Raed Al-Rajabi, Anwaar Saeed, Weijing Sun, Charles Porter> ;Journal of Oncology Pharmacy Practice. 2023 Dec 1
- Immune-Checkpoint Inhibitor (ICI) resumption after severe graft injury in a heart transplant recipient with nivolumab-sensitive metastatic melanoma and renal cell carc...Warren Tai, Gary C Doolittle, Zubair Shah, James B Atkinson, Elaine Russell, Randall E Genton, Javid J Moslehi, Charles B Porter> ;The Journal of Heart and Lung Transplantation. 2022 Dec 1
- 18 citationsImpact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States.Hayek, S., Sarju Ganatra, Sourbha S Dani, Ashish Kumar, Safi U Khan, Rishi Wadhera, Tomas G Neilan, Paaladinesh Thavendiranathan, Ana Barac, Joerg Hermann, Monika Leja...> ;JACC. Cardiooncology. 2022 Sep 1
- Join now to see all
Grant Support
- Cray Gift in Heart Failure and CardioOncologySally and Cloud Cray Jr Foundation2018–Present
Professional Memberships
- Fellow
- International Cardio-Oncology SocietyAmerican Vice President GCOS
Other Languages
- Spanish
Hospital Affiliations
The University of Kansas HospitalKansas City, Kansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
